SUBSCRIBE
SUBSCRIBE
News   FDA

Actelion Ltd.'s (JOBS) Tracleer Gets US Approval for Wider Use

August 10, 2009 | 
1 min read
Bookmark and Share

Reuters -- Europe's biggest biotech company Actelion Ltd said on Monday its Tracleer drug had been granted approval for mildly symptomatic pulmonary arterial hypertension (PAH).
FDA Approvals
MORE ON THIS TOPIC
Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration
FDA
UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy
July 27, 2026
 · 
3 min read
 · 
Heather McKenzie
3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
 · 
3 min read
 · 
Gabrielle Masson
A silhouette of a head with a pink brain inside, surrounded by various graphic elements, a light bulb, puzzle pieces, speech bubbles, a key and abstract doodles. The concept of thinking, creativity.
Approvals
Otsuka’s ADHD approval opens up new drug class with $615M opportunity
July 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Chess made from China and EU, USA flags. Europe Union, USA and China relations
China
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
July 27, 2026
 · 
10 min read
 · 
Heather McKenzie